Submission of intimation of trading window closure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals has informed BSE that the trading window for its securities is closed for designated persons and their relatives from December 8, 2025, until 48 hours after the outcome of a Board meeting is disclosed. The Board meeting is scheduled for December 11, 2025, to consider a proposal for raising funds, which may be done through a preferential issue of securities or any other permitted mode, or a combination of these. This is a standard compliance step under SEBI's Insider Trading Regulations ahead of a potentially price-sensitive corporate action. The company was formerly known as Trimurthi Limited.
The trading window closure itself does not move the share price, but signals that a fund-raising decision (likely a preferential allotment) is imminent, which could lead to equity dilution for existing shareholders depending on the issue price and size.